Bahto Biosciences

Bahto Biosciences develops non-opioid small-molecule therapeutics for painful peripheral neuropathy, a condition with limited effective treatment options that afflicts more than 19 million Americans.

Operating in lifetech based in Indianapolis, Indiana, Bahto Biosciences operates.

Profile

Bahto Biosciences is a health and lifetech company focused on developing non-opioid small-molecule therapeutics for painful peripheral neuropathy, a condition with limited effective treatment options. The company utilizes a proprietary chemical scaffold to generate novel composition-of-matter derivatives that have demonstrated in vivo efficacy. Bahto Biosciences aims to advance its lead candidate toward investigational new drug-enabling studies, potentially delivering the first disease-modifying therapy for this challenging condition. Founded by experienced drug discovery experts with a strong track record in advancing multiple drugs to clinical trials and successful asset development, Bahto Biosciences contributes to innovation by addressing unmet medical needs through pioneering therapeutic approaches.

As a business in lifetech, Bahto Biosciences is listed here with the public details available about it.

Indianapolis, Indiana is where the company is located.

Directory data places it at the Plug and Play accelerated startup stage.

Website: bahtobio.com